Drugs / glycyrrhizin acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05895773 | Jun → Nov 2023 | — | Menoufia University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glycyrrhizin acid | “Povidone Iodine 0.5% plus glycyrrhizin acid 2.5 mg/ml as a nasal and an oropharyngeal spray (mint flavored) will be applied 4 times per day.” NCT05895773 ↗ |
| Route | Intranasal | “as a nasal and an oropharyngeal spray” NCT05895773 ↗ |